Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-02-28 11:28:32

expired found date

-

created at

2024-06-05 01:25:33

updated at

2025-12-28 04:36:48

Domain name statistics

length

10

crc

63053

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

256482523

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

62320

mp size raw text

2610

mp inner links count

1

mp inner links status

20 (imported)

Open Graph

title

description

Developing novel, well-tolerated, oral treatments of cancer and its complications

image

site name

author

updated

2025-12-15 19:20:16

raw text

Cantex Pharmaceuticals | Developing novel, well-tolerated, oral treatments of cancer and its complications Our Company About Us Leadership Our Science Our Pipeline Therapeutic Targets Latest News Contact Us Our Company About Us Leadership Our Science Our Pipeline Therapeutic Targets Latest News Contact Us DEVELOPING NOVEL, WELL-TOLERATED, ORAL TREATMENTS FOR CANCER AND OTHER SERIOUS ILLNESSES Cantex is developing azeliragon, a novel antagonist of RAGE (the receptor for advanced glycation endproducts). LEARN MORE Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing novel, well-tolerated, oral treatments of cancer and other serious illnesses.   Cantex is led by Stephen Marcus, M.D., Neil Flanzraich and Juan Rodriguez; seasoned drug developers and pharmaceutical executives with stellar track records of developing blockbuster products and extensive transactional experience.   READ MORE Azeliragon is a safe, ...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Nowotwory (78)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

2093

text words

336

text unique words

163

text lines

54

text sentences

12

text paragraphs

7

text words per sentence

28

text matched phrases

11

text matched dictionaries

4

RSS

rss status

32 (unknown)

rss found date

2024-03-07 05:01:34

rss size orig

72149

rss items

10

rss spam phrases

0

rss detected language

1 (English)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)

sitemap review version

1

sitemap urls count

32

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-03-06 14:30:24

sitemap process date

2024-12-21 15:48:36

sitemap first import date

-

sitemap last import date

-